↓ Skip to main content


Article Metrics

Osteoprotegerin rich tumor microenvironment: implications in breast cancer

Overview of attention for article published in Oncotarget, April 2016
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (61st percentile)
  • Good Attention Score compared to outputs of the same age and source (75th percentile)

Mentioned by

5 patents
1 Facebook page


25 Dimensions

Readers on

33 Mendeley
Osteoprotegerin rich tumor microenvironment: implications in breast cancer
Published in
Oncotarget, April 2016
DOI 10.18632/oncotarget.8658
Pubmed ID

Sudeshna Goswami, Neelam Sharma-Walia


Osteoprotegerin (OPG) is a soluble decoy receptor for tumor necrosis factor (TNF)-related apoptosis inducing ligand (TRAIL). It belongs to the tumor necrosis factor receptor superfamily (TNFRSF). OPG was initially discovered to contribute to homeostasis of bone turnover due to its capability of binding to receptor activator of nuclear factor-kappaB (NF-kB). However, apart from bone turnover, OPG plays important and diverse role(s) in many biological functions. Besides having anti-osteoclastic activity, OPG is thought to exert a protective anti-apoptotic action in OPG-expressing tumors by overcoming the physiologic mechanism of tumor surveillance exerted by TRAIL. Along with inhibiting TRAIL induced apoptosis, it can induce proliferation by binding to various cell surface receptors and thus turning on the canonical cell survival and proliferative pathways. OPG also induces angiogenesis, one of the hallmarks of cancer, thus facilitating tumor growth. Recently, the understanding of OPG and its different roles has been augmented substantially. This review is aimed at providing a very informative overview as to how OPG affects cancer progression especially breast cancer.

Mendeley readers

The data shown below were compiled from readership statistics for 33 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 33 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 9 27%
Student > Bachelor 5 15%
Student > Master 5 15%
Student > Doctoral Student 4 12%
Professor 2 6%
Other 3 9%
Unknown 5 15%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 9 27%
Medicine and Dentistry 7 21%
Agricultural and Biological Sciences 5 15%
Immunology and Microbiology 3 9%
Pharmacology, Toxicology and Pharmaceutical Science 3 9%
Other 0 0%
Unknown 6 18%

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 12 July 2022.
All research outputs
of 21,717,421 outputs
Outputs from Oncotarget
of 14,142 outputs
Outputs of similar age
of 296,538 outputs
Outputs of similar age from Oncotarget
of 587 outputs
Altmetric has tracked 21,717,421 research outputs across all sources so far. This one has received more attention than most of these and is in the 67th percentile.
So far Altmetric has tracked 14,142 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.2. This one has done well, scoring higher than 75% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 296,538 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 61% of its contemporaries.
We're also able to compare this research output to 587 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 75% of its contemporaries.